These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9169302

  • 1. Controlled trials of inositol in psychiatry.
    Levine J.
    Eur Neuropsychopharmacol; 1997 May; 7(2):147-55. PubMed ID: 9169302
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.
    Benjamin J, Levine J, Fux M, Aviv A, Levy D, Belmaker RH.
    Am J Psychiatry; 1995 Jul; 152(7):1084-6. PubMed ID: 7793450
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder.
    Palatnik A, Frolov K, Fux M, Benjamin J.
    J Clin Psychopharmacol; 2001 Jun; 21(3):335-9. PubMed ID: 11386498
    [Abstract] [Full Text] [Related]

  • 4. Inositol treatment of obsessive-compulsive disorder.
    Fux M, Levine J, Aviv A, Belmaker RH.
    Am J Psychiatry; 1996 Sep; 153(9):1219-21. PubMed ID: 8780431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inositol treatment of autism.
    Levine J, Aviram A, Holan A, Ring A, Barak Y, Belmaker RH.
    J Neural Transm (Vienna); 1997 Sep; 104(2-3):307-10. PubMed ID: 9203092
    [Abstract] [Full Text] [Related]

  • 7. Myo-inositol has no beneficial effect on premenstrual dysphoric disorder.
    Nemets B, Talesnick B, Belmaker RH, Levine J.
    World J Biol Psychiatry; 2002 Jul; 3(3):147-9. PubMed ID: 12478879
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inositol treatment in psychiatry.
    Benjamin J, Agam G, Levine J, Bersudsky Y, Kofman O, Belmaker RH.
    Psychopharmacol Bull; 1995 Jul; 31(1):167-75. PubMed ID: 7675981
    [Abstract] [Full Text] [Related]

  • 10. Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial.
    Barak Y, Levine J, Glasman A, Elizur A, Belmaker RH.
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):729-35. PubMed ID: 8843494
    [Abstract] [Full Text] [Related]

  • 11. Lack of effect of 6 g inositol treatment of post-ECT cognitive function in humans.
    Levine J, Pomerantz T, Stier S, Belmaker RH.
    J Psychiatr Res; 1995 May; 29(6):487-9. PubMed ID: 8642546
    [Abstract] [Full Text] [Related]

  • 12. Acute inositol does not attenuate m-CPP-induced anxiety, mydriasis and endocrine effects in panic disorder.
    Benjamin J, Nemetz H, Fux M, Bleichman I, Agam G.
    J Psychiatr Res; 1997 May; 31(4):489-95. PubMed ID: 9352475
    [Abstract] [Full Text] [Related]

  • 13. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
    McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH.
    Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial.
    Jahanbakhsh SP, Manteghi AA, Emami SA, Mahyari S, Gholampour B, Mohammadpour AH, Sahebkar A.
    Complement Ther Med; 2016 Aug; 27():25-9. PubMed ID: 27515872
    [Abstract] [Full Text] [Related]

  • 16. CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia.
    Levine J, Goldberger I, Rapaport A, Schwartz M, Schield C, Elizur A, Belmaker RH, Shapiro J, Agam G.
    Eur Neuropsychopharmacol; 1994 Dec; 4(4):487-90. PubMed ID: 7894259
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

  • 18. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [Abstract] [Full Text] [Related]

  • 19. A Double-Blind Randomized Placebo-Controlled Pilot Study of Azithromycin in Youth with Acute-Onset Obsessive-Compulsive Disorder.
    Murphy TK, Brennan EM, Johnco C, Parker-Athill EC, Miladinovic B, Storch EA, Lewin AB.
    J Child Adolesc Psychopharmacol; 2017 Sep; 27(7):640-651. PubMed ID: 28358599
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.